Kura Oncology CEO Troy Wilson acquires 100,000 common shares valued at $1,239,000 - KURA News | RalliesKura Oncology CEO Troy Wilson acquires 100,000 common shares valued at $1,239,000
K
KURA• CEO share purchase disclosure
- Kura Oncology President and CEO Troy Edward Wilson disclosed a purchase of 100,000 common shares at a weighted average price of $12.39.
- The shares were reported as held indirectly through the One Fish Two Fish Revocable Trust.
- Wilson’s reported post-transaction holdings included 435,456 shares held directly, 479,194 shares held via the trust.
- Separate indirect holdings of 300,000 shares were reported through the Lorax Charitable Remainder Unitrust.
LEU
•
